ARKG vs VIG
ARK Genomic Revolution ETF vs Vanguard Dividend Appreciation ETF
- • VIG has the lower expense ratio at 0.04% vs 0.75% for ARKG.
- • VIG pays a higher dividend yield (1.51%).
Side-by-side metrics
| Metric | ARKG | VIG |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.75% | 0.04% |
Dividend yield Trailing 12-month yield. | 0.00% | 1.51% |
AUM Assets under management — bigger funds are typically more liquid. | $1.24B | $124.65B |
YTD return | 7.21% | 4.98% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 2.35 | 0.79 |
P/E ratio | — | 26.45 |
Last price | $30.38 | $228.11 |
Inception | — | — |
Issuer | ARK | Vanguard |
ARKG top holdings
| TEM | Tempus AI Inc Class A common stock | 9.45% |
| TWST | Twist Bioscience Corp | 9.02% |
| CRSP | CRISPR Therapeutics AG | 8.94% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 5.78% |
| BEAM | Beam Therapeutics Inc | 5.44% |
| ABSI | Absci Corp | 4.79% |
| NTRA | Natera Inc | 4.08% |
| ILMN | Illumina Inc | 4.04% |
| NTLA | Intellia Therapeutics Inc | 3.83% |
| PSNL | Personalis Inc | 3.59% |
VIG top holdings
| AVGO | Broadcom Inc | 4.07% |
| AAPL | Apple Inc | 4.03% |
| MSFT | Microsoft Corp | 3.81% |
| JPM | JPMorgan Chase & Co | 3.53% |
| LLY | Eli Lilly and Co | 3.48% |
| XOM | Exxon Mobil Corp | 3.38% |
| JNJ | Johnson & Johnson | 2.81% |
| WMT | Walmart Inc | 2.60% |
| V | Visa Inc Class A | 2.26% |
| COST | Costco Wholesale Corp | 2.11% |
About ARKG
ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $1.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Tempus AI Inc Class A common stock (TEM), which represents 9.4% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.
About VIG
VIG (Vanguard Dividend Appreciation ETF) is US companies with a record of growing dividends. Managed by Vanguard, the fund carries $124.6B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.51%. Its largest holding is Broadcom Inc (AVGO), which represents 4.1% of the portfolio. Consumer Cyclical is the fund's largest sector exposure at 5.0%.